Trials halted after bowel drug linked to heart risk
GlaxoSmithKline (GSK) and Adolor have halted development of an innovative drug designed to improve pain relief, amid concerns that the drug could cause heart problems.
Archives for April 9, 2007
Preclinical services news in brief
In this week's review of activity within the preclinical research services arena, new deals have emerged involving Argenta Discovery, SRI International and Discovery Partners International.
Mar Cor buys dialysis water business from GE
Mar Cor Purification has bought GE Water and Process Technologies' dialysis water business for $30.6m (€22.8m) to become the largest provider of dialysis water in the US, and plans to expand their presence in industrial life science markets.
Leveraging the detection of proteins to new limits
A new millimetre-sized cantilever biosensor has been developed that can detect cells and proteins at lower levels than ever before even under flow conditions, opening the way for new biomarker applications.
US equity market potential goldmine for biotech companies
The US equity market is open to biotech companies and it is a good time for them to raise money, delegates heard at Biotrinity in Oxfordshire, UK.
Multi-talented RFID tag hits pharma market
The first radio frequency identification (RFID) tag that authenticates, encrypts data and monitors product temperature hit the shelves last week, aimed specifically at protecting the pharmaceutical supply chain.
Jasco takes chromatography supercritical
A new range of preparative scale supercritical fluid chromatography (SFC) and extraction (SFE) products promises cheaper and faster separations and extractions.
Amgen to use contract manufacturers for expansion
Amgen has announced it will increase its reliance on third-party contract manufacturers as part of its ambitious expansion plans.
New machine targets clinical trials market
A British packaging machinery firm has launched a new machine for labs packing quality samples for clinical trials.